Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-20-025193

CFO & Executive Vice President gave up 248 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Sharp Shalini · CFO & Executive Vice President

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-04-19 Shares withheld for taxes : show line 1 in the form −248 $58.57 $14,525 103,584 D
Loading xslF345X03/doc4.xml…